What is it about?

A new stent to Treat May-Thurner Syndrome

Featured Image

Why is it important?

The Sinus-Obliquus® iliac venous stent (Optimed, Germany) is a self-expanding oblique hybrid nitinol stent to treat MTS. The stent has a proximal closed-cell section that provides high radial force at the blocked site; with an oblique design (35°) at the proximal end prevents jailing of the contralateral iliac vein or vena cava occlusion

Perspectives

Current endovascular technique brings excellent results in the recanalization of the iliac venous system, in that group of patients with exuberant symptomatology, subjecting the patient to minimal surgical trauma

Professor Paulo Eduardo Ocke Reis
Universidade Federal Fluminense

Read the Original

This page is a summary of: New Generation Venous Stent to Treat May-Thurner Syndrome, Journal of Vascular and Endovascular Surgery, January 2018, Scitechnol Biosoft Pvt. Ltd.,
DOI: 10.21767/2573-4482.100056.
You can read the full text:

Read

Contributors

The following have contributed to this page